Search Results

Filter Results

Reset filters

Date

All Dates

Past 7 Days 0

Past 30 Days 0

Past year 27

Custom range

Custom Date Range

Start date: End date:

Topic

All Topics

Public Health 2,052

COVID-19 1,189

States 1,082

Health Industry 776

Global Health Watch 515

Capitol Desk 391

Cost and Quality 381

California 339

Pharmaceuticals 277

Health Care Costs 256

Noticias En Español 244

Elections 203

Aging 174

Multimedia 168

Insurance 163

Mental Health 116

Medicaid 105

Race and Health 93

The Health Law 89

Medicare 86

Courts 68

Rural Health 63

Navigating Aging 38

Uninsured 37

Postcards 34

KFF Health News On Air 23

Health Care Reform 15

Medi-Cal 12

Asking Never Hurts 7

HealthBent 7

Covered California 4

KFF Health News Impact 3

Spotlight 2

The New Old Age 0

Audio Report 0

Content Type

All Content Types

Morning Briefing 1,171

Podcast 7

Story 1,354

Showing 2161-2180 of 2,537 results for "coronavirus"

Sort by Relevance Date

17-Year-Old’s Death Linked To Coronavirus, Emphasizing That The Young Aren’t Immune To The Outbreak

March 25, 2020 Morning Briefing

While the case is complex in terms of how COVID-19 played a role in the death, California Gov. Gavin Newsom and state health officials say it highlights the risk to young people, who have experienced far lower mortality rates than the older generations.

X
Facebook
LinkedIn
Email
Print

Gilead’s Promising Coronavirus Treatment Granted Orphan Drug Status That Provides Lucrative Incentives For Company

March 25, 2020 Morning Briefing

Gilead could keep lower-priced generic versions of the medicine off the market for several years if remdesivir is approved for use. Gilead was able to secure the status because as of now there are fewer than 200,000 cases in the U.S.

X
Facebook
LinkedIn
Email
Print

A Look At The Main Players Around The Globe Who Are Handling Coronavirus Outbreak

February 18, 2020 Morning Briefing

From HHS Secretary Alex Azar to Chinese President Xi Jinping to WHO director-general Tedros Adhanom Ghebreyesus, Stat takes a look at the big names behind the organizations and countries racing to contain the outbreak. Meanwhile, NIH’s Anthony Fauci says the outbreak is “on the verge” of becoming a global pandemic.

X
Facebook
LinkedIn
Email
Print

Global Health Watch: China Tries To Control Death Toll Narrative; Italy Starts Talking About How To Re-Open

April 6, 2020 Morning Briefing

China and Italy continue to cope with the fallout from massive coronavirus outbreaks, while experts look to Germany to examine how that nation has, so far, avoided one.

X
Facebook
LinkedIn
Email
Print

WHO Temporarily Halts Anti-Malarial Drug Trial For Safety Review

May 26, 2020 Morning Briefing

Previous studies have found negative side effects of hydroxychloroquine while so far it has not been proven to be an effective coronavirus treatment. President Donald Trump pushed for doctors to prescribe the drug and said he was taking a regime himself as a preventive measure.

X
Facebook
LinkedIn
Email
Print

Public Health Experts Warn About A Dangerous Symptom Of Coronavirus: Xenophobia

January 30, 2020 Morning Briefing

“More panic, more temptation to blame the outsider — the other,” says Robert Fullilove, a professor of sociomedical sciences at New York’s Columbia University Medical Center. Fullilove is among the experts who are warning that mass hysteria over the coronavirus could lend itself to bigotry and baseless fear.

X
Facebook
LinkedIn
Email
Print

Coronavirus Mostly Spreads Via Tight Social Clusters Which Scientists See As A Weakness To Be Exploited

March 23, 2020 Morning Briefing

Scientists say the way the illness is mostly spreading is through close contact between friends, family members and colleagues. That means if officials can get ahead of the outbreak, they can test and isolate and then perhaps hold off the worst of the spread. Meanwhile, despite a rising sense of urgency around the globe and governments’ directives to practice social distancing, there are some who still won’t listen.

X
Facebook
LinkedIn
Email
Print

The End Of Handshakes? Epidemiologists Weigh In On Comfort Levels With Pre-Pandemic Behavior

June 8, 2020 Morning Briefing

Epidemiologists say they feel safe going to the doctors or going on an overnight trip within driving distance. But, on the whole, they don’t see going to weddings or concerts within the next year. In other public health news: life in retail during the coronavirus, workplace safety, anxiety and more.

X
Facebook
LinkedIn
Email
Print

As COVID Hits Hard In Minority Communities, Concerns Rise About Mental Health And Suicide Risks

July 13, 2020 Morning Briefing

Social distancing urged by health officials to stave off the virus may lead to other health problems for some people with depression and anxiety. At the same time, new data looks at the toll in Black and Hispanic areas, and some communities are reaching out to minority neighborhoods to inform residents about efforts to stop the infections; plus other developments in the fight the coronavirus.

X
Facebook
LinkedIn
Email
Print

Stocks Plunge For Sixth Straight Day In Global Slide Triggered By Coronavirus Fears

February 28, 2020 Morning Briefing

The outbreak not only threatens global supply chains, but impacts the way consumers interact with the economy. “They stop going out to eat, they don’t take the vacation, they cancel the business trip — that consumption, that spending, personal consumption is 68 percent of G.D.P.,” said Scott Clemons, the chief investment strategist for private banking at Brown Brothers Harriman.

X
Facebook
LinkedIn
Email
Print

First Report Of A Coronavirus-Related Drug Shortage Could Herald Things To Come

February 28, 2020 Morning Briefing

The unnamed company that notified the FDA about a shortage said the problem is the result of an issue with the manufacturing of an active pharmaceutical ingredient used in the drug. “It is important to note that there are other alternatives that can be used by patients,” said FDA Commissioner Stephen Hahn.

X
Facebook
LinkedIn
Email
Print

Amid Coronavirus Outbreak, FDA Suspends Inspections Of Foreign Manufacturers Of Drugs, Medical Devices

March 11, 2020 Morning Briefing

FDA Commissioner Stephen Hahn said in a statement that the decision was based on State Department travel advisories and other restrictions that have been enforced during the outbreak.

X
Facebook
LinkedIn
Email
Print

Deadly Storms In South A Harsh Reminder Of The Difficulties That Come With Dueling Catastrophes

April 14, 2020 Morning Briefing

Tornadoes and severe weather storms left dozens dead in southern states that have been braced for a surge of the coronavirus. The disaster response will be severely hampered by the pandemic that is already devouring resources and attention.

X
Facebook
LinkedIn
Email
Print

Many Labs Say They Can Process Far More Tests Than Ordered. Experts Blame A Disorganized System.

April 29, 2020 Morning Briefing

Increased testing is crucial to returning to a semblance of normalcy, but the U.S. has failed since the beginning of the coronavirus outbreak to meet demand. Labs, however, say they have the capacity and they’re just not being used.

X
Facebook
LinkedIn
Email
Print

In An Abundance Of Caution, 2 Members Of Congress To Self-Quarantine After Contact With Coronavirus Patient

March 9, 2020 Morning Briefing

Sen. Ted Cruz (R-Texas) and Rep. Paul Gosar (R-Ariz.) said they are taking the precautions after crossing paths with the patient at the Conservative Political Action Conference. Some were worried that President Donald Trump, who attended the event, may have been exposed to the virus.

X
Facebook
LinkedIn
Email
Print

Both Democrats And Republicans Upset With How Trump Administration Is Handling Coronavirus Threat

February 26, 2020 Morning Briefing

Administration officials fielded questions from more than a dozen senators for about an hour while HHS Secretary Alex Azar and acting Homeland Security Secretary Chad Wolf faced sharp interrogations at a pair of Senate budget hearings. And criticism didn’t just come from the Democrats. “It seems to me at the outset that this request for the money, the supplemental, is low-balling it, possibly, and you can’t afford to do that,” Senate Appropriations Committee Chairman Richard Shelby (R-Ala.) said of the Trump administration’s initial emergency funding request. Meanwhile, the White House is scrambling to control the negative messaging around the virus as stocks plunge on fears of an outbreak.

X
Facebook
LinkedIn
Email
Print

First Person-To-Person Transmission Of Coronavirus Confirmed In U.S.

January 31, 2020 Morning Briefing

The patient is the husband of someone who had come back from Wuhan, China, the epicenter of the outbreak. “The risk to the general public remains low. This person-to-person spread was between two very close contacts, a husband and wife,” said Dr. Ngozi Ezike, director of the Illinois Department of Public Health. Meanwhile, as HHS Secretary Alex Azar takes the reins in dealing the with outbreak in the U.S., President Donald Trump still faces pressure as fears mount. Media outlets report on screenings, evacuations, possible cases in the states, and more.

X
Facebook
LinkedIn
Email
Print

Nearly 60,000 Cases In One Day: U.S. Sets Another Daily COVID-19 Record

July 9, 2020 Morning Briefing

Over 3.1 million cases have now been confirmed in the U.S. and the death toll is nearing 135,000. By Election Day, that number could grow to 200,000, according to a new projection. Florida and Texas continue to be two hot-spot states in the latest surge. Worldwide, known coronavirus infections pass the 12 million mark.

X
Facebook
LinkedIn
Email
Print

Private Lab Announces Portable 5-Minute Coronavirus Test Amid Nationwide Shortages, Slow Results

March 30, 2020 Morning Briefing

Many experts have pointed to the United States’ inability to test properly as a crucial failure in containing the crisis and say fixing that flaw is a major part of being able to return to normalcy. Abbot Laboratories gained FDA-approval for its quick test that it says could help health workers rapidly identify those who are actually sick. Meanwhile, the FDA still hasn’t approved any at-home kits, so those currently being promoted are unauthorized. And KHN looks at why the results take so long to get.

X
Facebook
LinkedIn
Email
Print

Novartis To Conduct Malaria Drug Study Even As Early Data Hint That It Doesn’t Fully Protect Against Coronavirus

April 20, 2020 Morning Briefing

The study will be a randomized, double-blind placebo-controlled study, unlike the research being done on the fly treating severely ill patients. The decision was announced as emerging data show people who are taking hydroxychloroquine are still becoming infected with the virus. Meanwhile, President Donald Trump’s tendency to tout possible cures in the early stages of testing is upending pharma’s traditional PR machine. And Reuters offers an overview of where we stand on drug and vaccines.

X
Facebook
LinkedIn
Email
Print

More From KFF Health News

A photo of a die-in staged at a statehouse.

Who’s Policing Opioid Settlement Spending? A Crowdsourced Database Might Help

Journalists Tally State and Local Health Care Implications of GOP Megabill

A photo of a teenager sitting in the frame of a doorway backlit by a room filled with daylight.

The Foster Care System Has a Suicide Problem. Federal Cuts Threaten To Slow Fixes.

Closeup of a doula assisting a pregnant woman by placing a belly band while she's sitting on a fitness ball, providing support and comfort during pregnancy

Doulas, Once a Luxury, Are Increasingly Covered by Medicaid — Even in GOP States